Complementary oligonucleotide sequence inhibits both Vmw65 gene expression and replication of herpes simplex virus

Area of Science:

• Virology
• Molecular Biology
• Antiviral Therapeutics

Background:

• Herpes simplex virus (HSV) is a significant human pathogen.
• The virion tegument protein Vmw65 is crucial for HSV immediate early gene transcription and viral replication.
• Targeting essential viral proteins offers a strategy for antiviral development.

Purpose of the Study:

• To investigate the potential of an antisense oligodeoxyribonucleotide to inhibit Vmw65 biological activity.
• To assess the impact of this oligodeoxyribonucleotide on HSV-1 yield in tissue culture.
• To evaluate the cellular toxicity of the oligodeoxyribonucleotide at effective concentrations.

Main Methods:

• Utilized an oligodeoxyribonucleotide complementary to the translation initiation region of Vmw65 mRNA.
• Assessed Vmw65 biological activity in a Vmw65-expressing cell line.
• Measured HSV-1 yield in infected tissue culture.
• Evaluated cellular toxicity of the oligodeoxyribonucleotide.

Main Results:

• The oligodeoxyribonucleotide significantly inhibited Vmw65 biological activity.
• A reduction in HSV-1 yield was observed in tissue culture.
• No observable cellular toxicity was detected at concentrations effective for inhibiting viral replication.

Conclusions:

• Antisense oligodeoxyribonucleotides targeting Vmw65 mRNA are a promising strategy for inhibiting HSV-1.
• This approach demonstrates efficacy in reducing viral yield without significant cellular toxicity.
• Further development of Vmw65-targeted therapies warrants investigation for HSV treatment.